11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml
Volume: 46, Issue: 4, Pages: 921 - 929
Published: Jan 10, 2019
Abstract
The main drawback of 11C-choline PET/CT for restaging prostate cancer (PCa) patients with biochemical failure is the relatively low positive detection rate for prostate specific antigen (PSA) < 1 ng/ml. This study assessed whether 11C-choline PET/CT predicts survival in PCa patients with PSA < 1 ng/ml. This retrospective study included 210 PCa patients treated with radical prostatectomy who underwent 11C-choline PET/CT from December 1, 2004 to...
Paper Details
Title
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml
Published Date
Jan 10, 2019
Volume
46
Issue
4
Pages
921 - 929
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History